What is it about?

We developed novel nanoparticles able to deliver curcumin into the brain. The study is the initial charaterisation of the new nanocarriers and evaluates safety and toxicity. We could also show an effect on Alzheimer’s disease pathology in vitro.

Featured Image

Read the Original

This page is a summary of: Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates, International Journal of Pharmaceutics, May 2017, Elsevier,
DOI: 10.1016/j.ijpharm.2017.05.015.
You can read the full text:

Read

Contributors

The following have contributed to this page